Bengaluru: Apollo Hospitals Bengaluru announces a groundbreaking achievement in cardiac surgery with the successful completion of a complex robotic procedure that saved the life of a 38-year-old Yemeni patient with long-standing mitral valve disease (MVD), in just 29 minutes. This remarkable procedure underscores Apollo's advanced medical capabilities and India's growing reputation for high-quality healthcare.

A 38-year-old patient from Yemen arrived at Apollo Hospitals Bannerghatta Road in dire need of intervention for his long-standing mitral valve disease. His condition was critical, characterized by mitral valve prolapse with severe regurgitation, moderate pulmonary arterial hypertension, and biventricular dysfunction with TAPSE of 12 mm. Biventricular dysfunction, as seen in this case, presents a multifaceted challenge with significant implications for patient outcomes. When the left and right ventricles do not function optimally, cardiac performance can be compromised, circulation impaired, and ultimately increased complications and death.

He underwent robotic mitral valve replacement (MVR) with a mechanical valve. The entire procedure, completed in just 29 minutes, marked a remarkable feat in cardiac surgery. Postoperative recovery was uneventful with no complications, and he was discharged on the third postoperative day. Mortality and morbidity rates were alarmingly high, underscoring the seriousness of his condition. A quick operating procedure plays a key role in obtaining better results. The decision to proceed with robotic mitral valve replacement yielded remarkable results, highlighting the potential benefits of innovative surgical techniques in mitigating the complexities associated with advanced cardiac pathologies.Sathyaki Nambala, Chief Cardiac Surgeon, Apollo Hospitals, Bengaluru, commented: "At Apollo Hospitals, our dedicated team of cardiologists, nurses and technicians work together to provide comprehensive care that addresses the entire spectrum of heart disease. Robotic mitral valve replacement, which we now routinely perform, exemplifies how advanced technology and "A multidisciplinary approach can transform complex cardiac surgeries into efficient, life-saving procedures. Completing this procedure in just 29 minutes is a testament to the robotic expertise of our team here, as well as our commitment to excellence in patient care."

In an era where cardiac surgery often involves lengthy procedures and recovery times, this achievement serves as a ray of hope for patients around the world. Apollo Hospitals has performed over 150 robotic mitral valve replacements to date, reinforcing India's status as a global leader in advanced cardiac care.

Dr Manish Mattoo, Regional CEO, Karnataka & Central Region, Apollo Hospitals, added: "We are deeply committed to providing healthcare of international standards at an affordable cost. Normally, a robotic surgery like this takes not less than 90 minutes. However, the immense experience and training that our team receives here has made this second nature to them, where they can produce excellent results in a shorter time. By integrating the latest technology and adopting a patient-centric approach, we are able to produce excellent results in a shorter time. We strive to ensure the best possible outcomes for our patients. Our goal is to continue strengthening our robotic cardiology program, leveraging innovations to provide timely and effective cardiac care to a broader population. which allowed him to be discharged quickly. He has since returned to Yemen and leads a normal life. This case highlights the potential benefits of innovative surgical techniques to address complex cardiac conditions and highlights the compassionate, patient-centered care provided at Apollo Hospitals.

About Apollo

Apollo revolutionized healthcare when Dr. PrathapReddy opened the first hospital in Chennai in 1983. Today, Apollo is the world's largest integrated healthcare platform with over 10,000 beds across 73 hospitals, nearly 6,000 pharmacies and more. of 2,500 clinics and diagnostic centers, as well as more than 500 telemedicine centers. Since its inception, Apollo has become one of the world's leading cardiac centers, having performed more than 300,000 angioplasties and 200,000 surgeries. Apollo continues to invest in research to deliver the most advanced technologies, equipment and treatment protocols to ensure patients receive the best care available in the world. The 100,000 members of the Apollo family are dedicated to providing you with the best care and leaving the world a better place than we found it. (Disclaimer: The above press release is provided by HT Syndication and will not take any editorial responsibility for this content.)